Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology.

Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology. Int J Cancer. 2005 Dec 20; 117(6):1007-12.

View in: PubMed

subject areas

Cervical Intraepithelial Neoplasia
Cervical Intraepithelial Neoplasia
Contraceptive Agents, Female
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral
DNA, Viral
DNA, Viral
Female
Female
Humans
Humans
Injections
Injections
Levonorgestrel
Levonorgestrel
Logistic Models
Logistic Models
Papanicolaou Test
Papanicolaou Test
Papillomaviridae
Papillomaviridae
Parity
Parity
Pregnancy
Pregnancy
Prospective Studies
Prospective Studies
Risk Factors
Risk Factors
Vaginal Smears
Vaginal Smears

authors with profiles

Joan L Walker